ALPHA PSYCHIATRY
Case Report

Management of Panic Disorder with Neurofeedback in Patients with Muscular Dystrophy: A Case Report

1.

Department of Psychiatry, Yeungnam University College of Medicine, Yeungi, Daegu, Republic of Korea

Alpha Psychiatry 2021; 22: 219-221
DOI: 10.5152/alphapsychiatry.2021.21135
Read: 837 Downloads: 36 Published: 30 June 2021

Duchenne muscular dystrophy (DMD) is the most common hereditary progressive muscular disease. It was recently reported that symptoms of anxiety and depression are frequent in patients with DMD, and psychosocial support is important for their quality of life. We reported 3 patients (2 patients with DMD and 1 patient with muscular dystrophy of an unknown etiology) with panic disorder and treated them successfully with neurofeedback (NFB). The NFB protocols were slow motor rhythm at T4 for 2 patients, beta training at F3 for 1 patient, and alpha/theta training at Pz for all patients. All patients had significantly improved anxiety symptoms, including panic attacks, after NFB therapy. NFB can be considered a safe therapeutic alternative without causing even minor side effects and without drug interactions for DMD patients with panic or anxiety disorders.

Cite this article as: Kim HG, Koo BH, Lee SW, Cheon EJ. Management of panic disorder with neurofeedback in patients with muscular dystrophy: a case report. Alpha Psychiatry. 2021;22(4):219-221.

Files
EISSN 2757-8038